Clinical applications of ultra-high field magnetic resonance imaging in multiple sclerosis.

Matilde Inglese, Lazar Fleysher, Niels Oesingmann, Maria Petracca

Journal: Expert review of neurotherapeutics 2019;18(3):221-230

PMID: 29369733

Abstract

Magnetic resonance imaging (MRI) is of paramount importance for the early diagnosis of multiple sclerosis (MS) and MRI findings are part of the MS diagnostic criteria. There is a growing interest in the use of ultra-high-field strength -7 Tesla- (7T) MRI to investigate, in vivo, the pathological substrate of the disease. Areas covered: An overview of 7T MRI applications in MS focusing on increased sensitivity for lesion detection, specificity of the central vein sign and better understanding of MS pathophysiology. Implications for disease diagnosis, monitoring and treatment planning are discussed. Expert commentary: 7T MRI provides increased signal-to-noise and contrast-to-noise-ratio that allow higher spatial resolution and better detection of anatomical and pathological features. The high spatial resolution reachable at 7T has been a game changer for neuroimaging applications not only in MS but also in epilepsy, brain tumors, dementia, and neuro-psychiatric disorders. Furthermore, the first 7T device has recently been cleared for clinical use by the food and drug administration.

Address: a Department of Neurology , Icahn School of Medicine , Mount Sinai , NY , USA.; b Department of Radiology , Icahn School of Medicine , Mount Sinai , NY , USA.; c Department of Neuroscience , Icahn School of Medicine , Mount Sinai , NY , USA.; d UK Biobank , Stockport , Cheshire , UK.; e Department of Neuroscience, Reproductive and Odontostomatological Sciences , Federico II University , Naples , Italy.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.